Results 211 to 220 of about 276,945 (256)
Some of the next articles are maybe not open access.

‘Second generation’ antidepressant drugs

Psychosomatics, 1981
Abstract After a long period of clinical use abroad, the “second generation” of antidepressant drugs has reached the United States. Although no claims are made that these new agents are more effective overall than the tricyclics, various advantages are claimed for them: more rapid onset of action, less sedative and anticholinergic side-effects, and ...
openaire   +2 more sources

Third-generation thrombolytic drugs

The American Journal of Medicine, 2000
Several third-generation thrombolytic agents have been developed. They are either conjugates of plasminogen activators with monoclonal antibodies against fibrin, platelets, or thrombomodulin; mutants, variants, and hybrids of alteplase and prourokinase (amediplase); or new molecules of animal (vampire bat) or bacterial (Staphylococcus aureus) origin ...
openaire   +2 more sources

Drug-Drug Interactions in General Anesthesia

Anesthesia & Analgesia, 1975
C B, Drain, K L, Campman
openaire   +2 more sources

Generic Drugs

New England Journal of Medicine, 1987
openaire   +2 more sources

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Generic drug products

American Journal of Health-System Pharmacy, 1989
openaire   +2 more sources

[Generic drug substitution].

Harefuah, 2007
The rapidly rising health care expenditures, attributed mainly to the high cost of prescription drugs, have led governments around the world to look to generics as a means of containing costs in the pharmaceutical market. Generic drugs provide a less expensive alternative to brand name drugs due to the elimination of the need to perform lengthy and ...
Orly, Tamir   +2 more
openaire   +1 more source

Generic drugs.

The Medical letter on drugs and therapeutics, 1986
openaire   +3 more sources

Home - About - Disclaimer - Privacy